Evidence map›Paper›PMID 35517819›Full record

ArticleFrontiers in pharmacology2022

Dysfunction of Inflammatory Pathways and Their Relationship With Psychological Factors in Adult Female Patients With Eating Disorders.

Javier R Caso, Karina S MacDowell, Marta Soto, Francisco Ruiz-Guerrero, Álvaro Carrasco-Díaz, Juan C Leza, José L Carrasco, Marina Díaz-Marsá

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Javier R CasoDepartamento de Farmacología y Toxicología, Facultad de Medicina, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Instituto Universitario de Investigación en Neuroquímica UCM, Universidad Complutense de Madrid, Madrid, Spain.
Karina S MacDowellDepartamento de Farmacología y Toxicología, Facultad de Medicina, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Instituto Universitario de Investigación en Neuroquímica UCM, Universidad Complutense de Madrid, Madrid, Spain.
Marta SotoDepartamento de Medicina Legal, Psiquiatría y Patología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Francisco Ruiz-GuerreroHospital Universitario Marqués de Valdecilla, Santander, Spain.
Álvaro Carrasco-DíazFacultad de Educación y Psicología, Universidad Francisco de Vitoria, Madrid, Spain.
Juan C LezaDepartamento de Farmacología y Toxicología, Facultad de Medicina, Instituto de Investigación Sanitaria Hospital 12 de Octubre (Imas12), Instituto Universitario de Investigación en Neuroquímica UCM, Universidad Complutense de Madrid, Madrid, Spain.
José L CarrascoCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
Marina Díaz-MarsáCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
Universidad Complutense de Madrid · ESCentro de Investigación Biomédica en Red de Salud Mental · ESInstituto de Investigación Sanitaria del Hospital Clínico San Carlos · ESMarqués de Valdecilla University Hospital · ESUniversidad Francisco de Vitoria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The attempts to clarify the origin of eating disorders (ED) have not been completely successful and their etiopathogenesis remains unknown. Current research shows an activation of the immune response in neuropsychiatric diseases, including ED. We aimed to investigate immune response parameters in patients with ED and to identify psychological factors influencing the inflammatory response. The relationship between inflammation markers and impulsivity and affective symptomatology was explored as well. Thirty-four adult female patients with current diagnosis of ED, none of them under psychopharmacological treatment (excluding benzodiazepines), were included in this study. Patients were compared with a healthy control group of fifteen adult females. The levels of inflammatory markers and indicators of oxidative/nitrosative stress were evaluated in plasma and/or in peripheral blood mononuclear cells (PBMCs). Subjects were assessed by means of different ED evaluation tools. Additionally, the Barratt Impulsiveness Scale, the Montgomery-Asberg Depression Rating Scale and the Hamilton Anxiety Rating Scale were also employed. Patients with ED shown increased plasma levels of the pro-inflammatory nuclear factor

Indexed as

affective disorderscytokinesdepressive symptomatologyeating disordersimpulsivity

Identifiers

PMID35517819
PMCPMC9062031
OpenAlexW4224300205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.